Sfoglia per AUTORE
BALDI I
Collezione ASL Vercelli

  

Items : 8

Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study in European Journal of Cancer

2015
ASL Biella
ASL Vercelli

Baili P; DI Salvo F; Marcos-Gragera R; Siesling S; Mallone S; Santaquilani M; Micheli A; Lillini R; Francisci S; Hackl M; Zielonke N; Oberaigner W; Van Eycken E; Henau K; Valerianova Z; DImitrova N; Sekerija M; Zvolský M; Dušek L; Storm H; Engholm G; Mägi M; Aareleid T; Malila N; Seppä K; Velten M; Troussard X; Bouvier V; Launoy G; et alii...

Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study in European Journal of Cancer

2015
ASL Biella
ASL Vercelli

Trama A; Foschi R; Larrañaga N; Sant M; Fuentes-Raspall R; Serraino D; Tavilla A; Eycken LV; Nicolai N; Hackl M; Zielonke N; Oberaigner W; Eycken EV; Henau K; Valerianova Z; Dimitrova N; Sekerija M; Zvolský M; Dušek L; Storm H; Engholm G; Mägi M; Aareleid T; Malila N; Seppä K; Velten M; Troussard X; Bouvier V; Launoy G; et alii...

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Salvage treatment with pomalidomide-cyclophosphamideprednisone produces similar outcomes as compared to prior therapies in patients with relapsed/refractory multiple myeloma in Haematologica

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Spriano M; Santagostino A; Genuardi M; Rota-Scalabrini D; Guglielmelli T; Giuliani N; Moscetti A; Mina R; Marcatti M; Galli M; Gilestro M; Crippa C; Baldi I; Rossi D; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone is active in lenalidomide relapsed/ refractory multiple myeloma in Clinical Lymphoma, Myeloma and Leukemia

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Rossi D; Crippa C; Genuardi M; Galli M; Marcatti M; Moscetti A; Giuliani N; Mina R; Guglielmelli T; Rota-Scalabrini D; Oddolo D; Santagostino A; Baldi I; Spriano M; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
ASL Vercelli

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;

High response rates to pomalidomide-cyclophosphamideprednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide: Results of a phase I/II study in Haematologica

2012
ASL Vercelli

Palumbo A; Larocca A; Lupo B; Montefusco V; Rossi D; Carella A; Crippa C; Santagostino A; Galli M; Rota Scalabrini D; Marcatti M; Guglielmelli T; Giuliani N; Laverde G; Magarotto V; Saraci E; Baldi I; Boccadoro M; Corradini P;

A phase I/II study of pomalidomide-cyclophosphamide-prednisone (PCP) in patients with multiple myeloma relapsed/refractory to lenalidomide in Blood

2011
ASL Vercelli

Palumbo A; Larocca A; Carella AM; Rossi D; Montefusco V; Ferrari S; Santagostino A; Guglielmelli T; Galli M; Capaldi A; Giuliani N; Verde GL; Omedè P; Baldi I; Boccadoro M; Corradini P;